Lars Østergaard

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial”.

Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial

The Lancet Microbe(2022)10.1016/s2666-5247(21)00239-1

N/A

0.663DataRank · unranked

82 citations

Jesper D Gunst, Yehuda Z Cohen, Marie H Pahus, Jakob J Malin, Martin Platten +20 more

Nanobody‐mediated complement activation to kill HIV‐infected cells

EMBO Molecular Medicine(2023)10.15252/emmm.202216422

N/A

0DataRank · unranked

14 citations

Dennis Pedersen, Mikael Winkler, Heidi Gytz Olesen, Ole S. Søgaard, Lars Østergaard +4 more